Danish biotech company Draupnir Bio raises €12M to tackle disease-causing proteins
Copenhagen-based Draupnir Bio, a biotechnology company, announced recently that it has secured €12M from MP Healthcare, the corporate venture group of Mitsubishi Tanabe Pharma Corporation, and the Export and Investment Fund of Denmark (EIFO), a financing fund backed by the Danish government.